Your browser doesn't support javascript.
loading
Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study.
Almeida, Antonio M; Prebet, Thomas; Itzykson, Raphael; Ramos, Fernando; Al-Ali, Haifa; Shammo, Jamile; Pinto, Ricardo; Maurillo, Luca; Wetzel, Jaime; Musto, Pellegrino; Van De Loosdrecht, Arjan A; Costa, Maria Joao; Esteves, Susana; Burgstaller, Sonja; Stauder, Reinhard; Autzinger, Eva M; Lang, Alois; Krippl, Peter; Geissler, Dietmar; Falantes, Jose Francisco; Pedro, Carmen; Bargay, Joan; Deben, Guillermo; Garrido, Ana; Bonanad, Santiago; Diez-Campelo, Maria; Thepot, Sylvain; Ades, Lionel; Sperr, Wolfgang R; Valent, Peter; Fenaux, Pierre; Sekeres, Mikkael A; Greil, Richard; Pleyer, Lisa.
Affiliation
  • Almeida AM; Instituto Português de Oncologia de Lisboa (IPOL), 1200-795 Lisbon, Portugal. amalmeida@ipolisboa.min-saude.pt.
  • Prebet T; Institut Paoli Calmettes, Marseille, France and Yale New Haven Hospital, New Haven, CT 06512, USA. thomas.prebet@yale.edu.
  • Itzykson R; Hopital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris Diderot University, 75010 Paris, France. itzykson@gmail.com.
  • Ramos F; Hospital Universitario de Leon, 24071 Leon, Spain. mail@fernandoramosmd.es.
  • Al-Ali H; University Hospital of Halle, 06120 Halle, Germany. alah@medizin.uni-leipzig.de.
  • Shammo J; Rush University Medical Center, Chicago, IN 60612, USA. Jamile_Shammo@rush.edu.
  • Pinto R; Hospital Sao Joao, 4200-319 Porto, Portugal. rjsmpinto@gmail.com.
  • Maurillo L; University Tor Vergata, 00173 Rome, Italy. luca.maurillo@uniroma2.it.
  • Wetzel J; Cleveland Clinic Taussig Cancer Institute, Cleveland, OH 44195, USA. FENSTEJ@ccf.org.
  • Musto P; RCCS-CROB, Referral Cancer Center of Basilicata, 85028 Rionero in Vulture (Pz), Italy. p.musto@tin.it.
  • Van De Loosdrecht AA; Department of Hematology VU University Medical Center, 1081 HV Amsterdam, The Netherlands. a.vandeloosdrecht@vumc.nl.
  • Costa MJ; Centro Hospitalar Lisboa Norte Hospital Santa Maria, 1649-035 Lisbon, Portugal. mjoaocosta@gmail.com.
  • Esteves S; Instituto Português de Oncologia de Lisboa (IPOL), 1200-795 Lisbon, Portugal. sesteves@ipolisboa.min-saude.pt.
  • Burgstaller S; Department of Internal Medicine IV, Hospital Wels-Grieskirchen, 4600 Wels, Austria. sonja.burgstaller@klinikum-wegr.at.
  • Stauder R; Department of Internal Medicine V (Haematology and Oncology), Innsbruck Medical University, 6020 Innsbruck, Austria. reinhard.stauder@i-med.ac.at.
  • Autzinger EM; 1st Department of Internal Medicine, Center for Oncology and Hematology, Wilhelminenspital, 1160 Vienna, Austria. eva-maria.autzinger@wienkav.at.
  • Lang A; Internal Medicine, Hospital Feldkirch,6800 Feldkirch, Austria. alois.lang@lkhf.at.
  • Krippl P; Department of Internal Medicine, Hospital Fürstenfeld, 8280 Fürstenfeld, Austria. peter.krippl@lkh-fuerstenfeld.at.
  • Geissler D; Department for Internal Medicine, Klinikum Klagenfurt am Wörthersee, 9020 Pörtschach am Wörthersee, Austria. dietmar.geissler@kabeg.at.
  • Falantes JF; Hospital Universitario Virgen del Rocio, 41013 Sevilla, Spain. jfalantes@gmail.com.
  • Pedro C; Hospital del Mar, 08003 Barcelona, Spain. MPedro@parcdesalutmar.cat.
  • Bargay J; Hospital Son Llatzer, 07198 Palma de Mallorca, Spain. jbargay@hsll.es.
  • Deben G; Hospital Universitario, 15006 A Coruña, Spain. gdebari@canalejo.org.
  • Garrido A; Hospital de la Santa Creu i Sant Pau, 08026 Barcelona, Spain. AGarridoD@santpau.cat.
  • Bonanad S; Hospital Universitario de la Ribera, 46600 Alzira, Spain. sbonanad@gmail.com.
  • Diez-Campelo M; Hospital Universitario de Salamanca, 37007 Salamanca, Spain. mdiezcampelo@usal.es.
  • Thepot S; Centre Hospitalier Universitaire, 49100 Angers, France. Sylvain.Thepot@chu-angers.fr.
  • Ades L; Hopital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris Diderot University, 75010 Paris, France. lionel.ades@sls.aphp.fr.
  • Sperr WR; Department of Internal Medicine I, Division of Hematology & Hemostaseology and Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, 1090 Vienna, Austria. wolfgang.r.sperr@meduniwien.ac.at.
  • Valent P; Department of Internal Medicine I, Division of Hematology & Hemostaseology and Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, 1090 Vienna, Austria. peter.valent@meduniwien.ac.at.
  • Fenaux P; Hopital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris Diderot University, 75010 Paris, France. pierre.fenaux@sls.aphp.fr.
  • Sekeres MA; Cleveland Clinic Taussig Cancer Institute, Cleveland, OH 44195, USA. SEKEREM@ccf.org.
  • Greil R; 3rd Med. Department, Paracelsus Medical University, 5020 Salzburg, Austria. r.greil@salk.at.
  • Pleyer L; Salzburg Cancer Research Institute, 5020 Salzburg, Austria. r.greil@salk.at.
Int J Mol Sci ; 18(4)2017 Apr 14.
Article in En | MEDLINE | ID: mdl-28420120
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Leukemia, Erythroblastic, Acute Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Int J Mol Sci Year: 2017 Type: Article Affiliation country: Portugal
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Leukemia, Erythroblastic, Acute Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Int J Mol Sci Year: 2017 Type: Article Affiliation country: Portugal